Seliciclib
id:
seliciclib-311-13284498
title:
Seliciclib
text:
Seliciclib is an experimental drug candidate in the family of pharmacological cyclin-dependent kinase (CDK) inhibitors that preferentially inhibit multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase or state within the cell cycle of treated cells. Seliciclib is being developed by Cyclacel.This is a phase II, dose ranging, multicenter, randomized, double-blind, placebo-controlled study. The aim of this study is to assess the safety of increasing doses of roscovitin
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Seliciclib
date created:
date modified:
2024-03-22T10:48:41Z
main entity:
{"identifier":"Q3494619","url":"https://www.wikidata.org/entity/Q3494619"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e0/Seliciclib_structure.svg","width":512,"height":551}
fields total:
13
integrity:
15